Cargando…

Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon

BACKGROUND: Sub-Saharan African market is highly affected by counterfeit veterinary drugs. Though these counterfeit and non-compliance of drugs can induce adverse effects during their utilization, there is no monitoring system of veterinary medicines. The present pilot study was carried out in Camer...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouiche, Mohamed Moctar Mouliom, Njingou, Badou Zaki Ndouoya, Moffo, Frédéric, Mpouam, Serge Eugene, Feussom, Jean Marc Kameni, Awah-Ndukum, Julius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701137/
https://www.ncbi.nlm.nih.gov/pubmed/31426790
http://dx.doi.org/10.1186/s12917-019-2043-1
_version_ 1783445006903672832
author Mouiche, Mohamed Moctar Mouliom
Njingou, Badou Zaki Ndouoya
Moffo, Frédéric
Mpouam, Serge Eugene
Feussom, Jean Marc Kameni
Awah-Ndukum, Julius
author_facet Mouiche, Mohamed Moctar Mouliom
Njingou, Badou Zaki Ndouoya
Moffo, Frédéric
Mpouam, Serge Eugene
Feussom, Jean Marc Kameni
Awah-Ndukum, Julius
author_sort Mouiche, Mohamed Moctar Mouliom
collection PubMed
description BACKGROUND: Sub-Saharan African market is highly affected by counterfeit veterinary drugs. Though these counterfeit and non-compliance of drugs can induce adverse effects during their utilization, there is no monitoring system of veterinary medicines. The present pilot study was carried out in Cameroon to identify and describe suspected cases of adverse reactions to veterinary drugs in animals and / or humans as well as inefficacy of veterinary drugs. The methodology involved a descriptive cross-sectional survey of 67 actors in the veterinary medicine sector in Cameroon. RESULTS: A total of 74/120 (62%) cases of suspected adverse effects and or lack of efficacy of veterinary drugs in animals and 46 (38%) cases of adverse reactions in humans were identified. Antiparasitics were the most incriminated therapeutic class in animals (61%) and human (56%). Adverse reactions were reported in dogs (44%) and poultry (24%) while drug inefficacy was most observed in poultry (47%). According to animal health professionals, levamisole (24%) and ivermectin (16%) were identified to be responsible for the adverse effects and that the highest level of inefficacy was most frequently reported for oxytetracycline (29%). The main adverse reactions were systemic (22%), gastrointestinal (20%) and neurological (13%) disorders. CONCLUSION: The results of this study showed that misuse and circulation of poor quality as well as lack of efficacy of veterinary drugs is very common in Cameroon. Adverse reactions were observed in animals and humans. Therefore, the establishment of a national veterinary pharmacovigilance system based on solid legal bases is essential for a continuous assessment of the risks-benefits effects of veterinary drugs marketed in Cameroon. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12917-019-2043-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6701137
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67011372019-08-26 Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon Mouiche, Mohamed Moctar Mouliom Njingou, Badou Zaki Ndouoya Moffo, Frédéric Mpouam, Serge Eugene Feussom, Jean Marc Kameni Awah-Ndukum, Julius BMC Vet Res Research Article BACKGROUND: Sub-Saharan African market is highly affected by counterfeit veterinary drugs. Though these counterfeit and non-compliance of drugs can induce adverse effects during their utilization, there is no monitoring system of veterinary medicines. The present pilot study was carried out in Cameroon to identify and describe suspected cases of adverse reactions to veterinary drugs in animals and / or humans as well as inefficacy of veterinary drugs. The methodology involved a descriptive cross-sectional survey of 67 actors in the veterinary medicine sector in Cameroon. RESULTS: A total of 74/120 (62%) cases of suspected adverse effects and or lack of efficacy of veterinary drugs in animals and 46 (38%) cases of adverse reactions in humans were identified. Antiparasitics were the most incriminated therapeutic class in animals (61%) and human (56%). Adverse reactions were reported in dogs (44%) and poultry (24%) while drug inefficacy was most observed in poultry (47%). According to animal health professionals, levamisole (24%) and ivermectin (16%) were identified to be responsible for the adverse effects and that the highest level of inefficacy was most frequently reported for oxytetracycline (29%). The main adverse reactions were systemic (22%), gastrointestinal (20%) and neurological (13%) disorders. CONCLUSION: The results of this study showed that misuse and circulation of poor quality as well as lack of efficacy of veterinary drugs is very common in Cameroon. Adverse reactions were observed in animals and humans. Therefore, the establishment of a national veterinary pharmacovigilance system based on solid legal bases is essential for a continuous assessment of the risks-benefits effects of veterinary drugs marketed in Cameroon. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12917-019-2043-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-19 /pmc/articles/PMC6701137/ /pubmed/31426790 http://dx.doi.org/10.1186/s12917-019-2043-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mouiche, Mohamed Moctar Mouliom
Njingou, Badou Zaki Ndouoya
Moffo, Frédéric
Mpouam, Serge Eugene
Feussom, Jean Marc Kameni
Awah-Ndukum, Julius
Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
title Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
title_full Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
title_fullStr Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
title_full_unstemmed Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
title_short Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
title_sort veterinary pharmacovigilance in sub-sahara africa context: a pilot study of adverse reactions to veterinary medicine in cameroon
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701137/
https://www.ncbi.nlm.nih.gov/pubmed/31426790
http://dx.doi.org/10.1186/s12917-019-2043-1
work_keys_str_mv AT mouichemohamedmoctarmouliom veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon
AT njingoubadouzakindouoya veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon
AT moffofrederic veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon
AT mpouamsergeeugene veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon
AT feussomjeanmarckameni veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon
AT awahndukumjulius veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon